English | Español
Patient Daily | Mar 25, 2026

Roche ends development of spinal muscular atrophy drug after trial results
Patient Daily | Mar 25, 2026

Home-based chemotherapy proves to be safe and feasible in pilot study
Patient Daily | Mar 25, 2026

University of Michigan study finds urban living linked to lower first-time stroke risk
Patient Daily | Mar 25, 2026

Blood-based test may help guide breast cancer treatment for older women
Patient Daily | Mar 25, 2026

Study finds insulin caps lower out-of-pocket costs for Medicare beneficiaries
Patient Daily | Mar 25, 2026

Northwestern University study finds new biomarker and treatment for schizophrenia cognitive symptoms
Patient Daily | Mar 25, 2026

Study examines effects of artificial sweeteners on appetite and food intake
Patient Daily | Mar 25, 2026

Study links rising global temperatures to increased inactivity and premature deaths by 2050

Trending
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'